Skip to Main Content

Jesse M. Cedarbaum

MD, FAAN (Neurology), FANA

Contact Information

Jesse M. Cedarbaum, MD, FAAN (Neurology), FANA

Office Location


A 1978 YSM graduate, I am a neurologist/clinical trialist with sub-specialty in Movement Disorders. After 7 years heading the Parkinson and Movement Disorders program at New York-Hospital Cornell, I have spent the majority of his career as an executive in the pharmaceutical industry, leading teams in the areas of neurodegenerative, neuropsychiatric and retinal disorders at Regeneron, Elan, Cytokinetics and Bristol-Myers Squibb. Most recently I led a team at Biogen that advanced 3 new compounds into the clinic for potential treatment of Parkinson’s disease. At Biogen I also established a clinical research program in inherited ataxias. My research activities have encompassed efforts to develop novel clinical outcome measures and biomarkers, including digital health technologies for clinical trials. I have served as chair of the ADNI Private Partner Scientific Board, the Industry Scientific Advisory Board of the Michael J. Fox Foundation-sponsored Parkinson Progression Markers Initiative, and as industry co-chair of the Critical Path for Parkinson’s consortium. I have authored or-co-authored over 100 papers and book chapters, mostly in the area of neurological and opthalmological therapeutics , especially therapeutic development for Movement Disorders

Education & Training

  • Resident
    New York Hospital-Cornell Medical Center (1983)
  • Intern and Resident
    University of Chicago Hospitals and Clinics (1980)
  • MD
    Yale University School of Medicine (1978)
  • MA
    Stanford University, Biology
  • AB
    Stanford University, Human Biology


  • Board Certification
    AB of Psychiatry & Neurology, Neurology (1985)

Departments & Organizations